89BIO (ETNB)
(Real Time Quote from BATS)
$9.58 USD
-0.11 (-1.14%)
Updated Aug 6, 2025 03:22 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ETNB 9.58 -0.11(-1.14%)
Will ETNB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ETNB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ETNB
Viking Therapeutics Q1 Loss Wider Than Expected, Sales Nil, Stock Dips
Vaxcyte Stock Plummets 56% in a Month: Here's the Reason
ETNB: What are Zacks experts saying now?
Zacks Private Portfolio Services
VALN Doses First Infant With Shigella Vaccine in Mid-Stage Study
VRTX Secures Nod for Expanded Use of CF Drug Kaftrio in Europe
FDA Grants Three Fast Track Tags to Allogene's Autoimmune Disease Drug
Other News for ETNB
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ETNB Stock News
Altimmune: Potential Tough Road Ahead Amid Fierce Competition (Rating Downgrade)
89bio Inc (ETNB) Announces Inducement Grants for New Employees | ETNB stock news
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ETNB Stock News
Empery Asset Management, LP Reduces Stake in Volcon Inc